Zosano Pharma Corp 3 SEC Filings

Filed On	Filing
09 Dec 2021	Form 3: Yang Elaine, Director No securities owned
25 May 2021	Form 3: McGee Kathy M., Director No securities owned
03 Feb 2020	Form 3: Matthews Christine, See Remarks
23 Oct 2019	Form 3: Lo Steven, Director No securities owned
16 Jan 2019	Form 3: Grais Linda S, Director No securities owned
16 Oct 2018	Form 3: Kitchener Gregory David, Chief Financial Officer No securities owned
09 Apr 2018	Form 3: Aisling Capital IV, Lp, 10% owner and 2 others Holds 1,600,000 shares of Common Stock, par value of $0.0001
05 Oct 2017	Form 3: Greathouse Kenneth, Director No securities owned
28 Mar 2017	Form 3: Amzak Capital Management, Llc, 10% owner and 2 others Holds 5,151,813 shares of Common Stock, par value of $0.0001
24 Jun 2016	Form 3: Scharin Eric, VP, Engineering & Operations
24 Jun 2016	Form 3: Lewis Hayley, VP, Reg Affairs & QA
24 Jun 2016	Form 3: Kellerman Donald J, VP, Clinical Dev & Med Affairs
24 Jun 2016	Form 3: Erbez Georgia, Interim CFO No securities owned
06 May 2016	Form 3: Walker John Peter, Director No securities owned
01 Oct 2015	Form 3: Alataris Konstantinos, President No securities owned
27 May 2015	Form 3: Hagan Joseph P, Director No securities owned
07 May 2015	Form 3: Peri Laxmi, Sr. Vice President, Operations No securities owned
09 Feb 2015	Form 3: Lilly Eli & Co, 10% owner Holds 1,363,636 shares of Common Stock
26 Jan 2015	Form 3: BioMed Realty Trust Inc, 10% owner and 1 other Holds 454,243 shares of Common Stock
26 Jan 2015	Form 3: Xanthopoulos Kleanthis G, Director

Comments